[Rhabdomyolysis in cardiac transplant recipient due to verapamil interaction with simvastatin and cyclosporin treatment]

Therapie. 2003 Mar-Apr;58(2):168-70. doi: 10.2515/therapie:2003026.

[Article in French]

Authors

Anne Chiffoleau, Jean-Noël Trochu, Gwenaëlle Veyrac, Thierry Petit, Patrick Abadie, Michel Bourin, Pascale Jolliet

PMID: 12942860
DOI: 10.2515/therapie:2003026

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Calcium Channel Blockers / adverse effects*
Cyclosporine / adverse effects*
Drug Interactions
Heart Transplantation / physiology*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Immunosuppressive Agents / adverse effects*
Male
Middle Aged
Rhabdomyolysis / chemically induced*
Rhabdomyolysis / physiopathology
Simvastatin / adverse effects*
Verapamil / adverse effects*

Substances

Calcium Channel Blockers
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Immunosuppressive Agents
Cyclosporine
Simvastatin
Verapamil